Basem M. William

Basem M. William's research focuses on lymphoma and blood cancer treatment, particularly CAR-T cell therapy (a treatment that reprograms a patient's own immune cells to attack cancer), stem cell transplantation, and clinical trials for relapsed or hard-to-treat lymphomas. His work includes large multicenter clinical trials, treatment guidelines, and studies on monitoring disease using blood-based tumor DNA tests. This work is clinically oriented, involving collaboration on trials that evaluate new cancer therapies and their long-term outcomes in patients.

Publication output rose steadily from 2017 to a peak around 2019-2020, then became more variable with a notable dip in 2022 followed by partial recovery, suggesting an overall slowing trend in the most recent five years compared to the prior period.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026